Cliff Asness’s Akero Therapeutics AKRO Stock Holding History

Cliff Asness’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-65,966	Closed	-$3.13M	–	3565
2025 Q3	$3.13M	Buy	65,966 +32,219	+95%	+$1.56M	﹤0.01%	1717
2025 Q2	$1.8M	Buy	33,747 +27,984	+486%	+$1.27M	﹤0.01%	1845
2025 Q1	$233K	Sell	5,763 -2,889	-33%	-$122K	﹤0.01%	2811
2024 Q4	$241K	Buy	+8,652	New	+$262K	﹤0.01%	2596
2024 Q1	–	Sell	-16,767	Closed	-$392K	–	2406
2023 Q4	$392K	Buy	16,767 +5,868	+54%	+$116K	﹤0.01%	1978
2023 Q3	$551K	Sell	10,899 -7,135	-40%	-$332K	﹤0.01%	1820
2023 Q2	$842K	Sell	18,034 -11,962	-40%	-$548K	﹤0.01%	1624
2023 Q1	$1.15M	Buy	29,996 +16,313	+119%	+$727K	﹤0.01%	1491
2022 Q4	$750K	Buy	+13,683	New	+$586K	﹤0.01%	1656

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cliff Asness's AKRO Position: Q4 2025 in Review

Cliff Asness sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 65,966 shares — an estimated $3.13M sold.

Cliff Asness first reported a position in AKRO in Q4 2022 and held it in 9 quarters. The position peaked at $3.13M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Cliff Asness reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Cliff Asness sold 65,966 Akero Therapeutics shares in Q4 2025, an estimated $3.13M.
Cliff Asness first reported a position in Akero Therapeutics in Q4 2022 and held it in 9 quarters.
Cliff Asness's Akero Therapeutics position peaked at $3.13M in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.